UnitedHealth Group’s OptumRx PBM will put biosimilar versions of Abbvie’s expensive rheumatoid arthritis drug Humira “in the same position as the brand” on the PBM’s preferred list of drugs known as a formulary, in 2023.
Subscribe to:
Post Comments (Atom)
< + > Does Healthcare Need to Build a New Internet for AI Agents?
I’m blessed to go to a lot of healthcare IT conferences . I’ve heard just about every keynote speaker imaginable. I’ve heard amazing keyno...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
The following is a guest article by Ladd Wiley, Senior Vice President for Global Corporate Affairs, Public Policy, and Advocacy at Epic , ...
-
Robert Connely of Pega says patching legacy systems will give way to true health IT modernization, a security breakthrough will lead artific...
No comments:
Post a Comment